advertisement
11.3.4 Betablocker (14)
Showing records 1 to 14
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker6682 Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing
Tan AY; Levatte TL; Archibald ML; Tremblay F; Kelly ME; Chauhan BC
Journal of Glaucoma 2002; 11:134-142
6700 Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study
Bergstrand IC; Heijl A; Harris A
Acta Ophthalmologica Scandinavica 2002; 80: 176-182
6703 Color Doppler imaging of retrobulbar hemodynamics after topical carteolol in normal tension glaucoma
Chen MJ; Chou JC; Chiou HJ; Hsu WM
Zhonghua Yi Xue Za Zhi 2001; 64: 575-580
6713 Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow
Sato T; Muto T; Ishibashi Y; Roy S
Current Eye Research 2001; 23: 298-306
6872 A short term study of the additive effect of timolol and brimonidine on intraocular pressure
Arici MK; Sayici M; Toker M; Erdogan H; Topalkara A
Eye 2002; 16: 39-43
6877 Clinical and economic impact of new trends in glaucoma treatment
Marchetti A; Magar R; An P; Nichol M
Medscape General Medicine 2001; 3:6
6882 The beta-blocker carteolol inhibits contractions induced by KCl in pig ciliary arteries: an effect modulated by extracellular Ca++
Brogiolo G; Flammer J; Haefliger IO
Klinische Monatsblätter für Augenheilkunde 2002; 219: 268-272
6883 Ocular blood flow comparative analysis between betaxolol 0.5% and timolol 0.5%: prospective study
De Figueiredo CR; Suzuki ER Jr; De Figueiredo BP; Batista WD
Revista Brasileira de Oftalmologia 2001; 60: 777-780
6884 Effects of timolol and dorzolamide on retrobulbar hemodynamics in patients with newly diagnosed primary open-angle glaucoma
Galassi F; Sodi A; Renieri G; Ucci F; Pieri B; Harris A; Siesky B
Ophthalmologica 2002; 216: 123-128
6885 Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (Timolol GFS) in open angle glaucoma in India: preliminary safety and efficacy study
Kumar H; Sudan R; Sethi HS; Sony P
Indian Journal of Ophthalmology 2002; 50: 21-23
6886 Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes
Sharif NA; Xu SX; Crider JY; McLaughlin M; Davis TL
Journal of Ocular Pharmacology and Therapeutics 2001; 17: 305-317
6887 Alginic acid effect on carteolol ocular pharmacokinetics in the pigmented rabbit
Tissie G; Sebastian; Elena PP; Driot JY; Trinquand C
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 65-73
6888 Effect of topical betaxolol on the acute rise of aqueous flare induced by highly selective agonists for prostaglandin E2 receptor subtypes in pigmented rabbits
Yanagisawa S; Hayasaka S; Zhang XY; Hayasaka Y; Nagaki Y; Kitagawa K
Ophthalmic Research 2002; 34: 48-50
6889 Effect of topical betaxolol on acute rise of aqueous flare induced by prostaglandin E(2) in pigmented rabbits
Yanagisawa S; Hayasaka S; Zhang XY; Hayasaka Y; Nagaki Y; Kitagawa K
Japanese Journal of Ophthalmology 2001; 45: 669-671
